Tags

Type your tag names separated by a space and hit enter

[Continuous subcutaneous morphine to patients with terminal cancer. Analgesia at home].
Ugeskr Laeger. 1994 Apr 04; 156(14):2095-6.UL

Abstract

Since 1992 it has been possible for cancer patients in the county of Southern Jutland to receive terminal care in their own homes. An essential part of this management is effective pain relief; more than 60% of cancer patients have chronic pain. In cases where oral medication or epidural administration of morphine is insufficient or complicated by side-effects continuous subcutaneous morphine administration may be suitable. The patient may be treated in this latter manner for long periods of time. A case story is described where a cancer patient was treated with continuous subcutaneous morphine in his home for more than 257 days without complications or major side-effects.

Authors+Show Affiliations

Kirurgisk afdeling, Aabenraa Sygehus.

Pub Type(s)

Case Reports
English Abstract
Journal Article

Language

dan

PubMed ID

7516101

Citation

Laursen, J O.. "[Continuous Subcutaneous Morphine to Patients With Terminal Cancer. Analgesia at Home]." Ugeskrift for Laeger, vol. 156, no. 14, 1994, pp. 2095-6.
Laursen JO. [Continuous subcutaneous morphine to patients with terminal cancer. Analgesia at home]. Ugeskr Laeger. 1994;156(14):2095-6.
Laursen, J. O. (1994). [Continuous subcutaneous morphine to patients with terminal cancer. Analgesia at home]. Ugeskrift for Laeger, 156(14), 2095-6.
Laursen JO. [Continuous Subcutaneous Morphine to Patients With Terminal Cancer. Analgesia at Home]. Ugeskr Laeger. 1994 Apr 4;156(14):2095-6. PubMed PMID: 7516101.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Continuous subcutaneous morphine to patients with terminal cancer. Analgesia at home]. A1 - Laursen,J O, PY - 1994/4/4/pubmed PY - 1994/4/4/medline PY - 1994/4/4/entrez SP - 2095 EP - 6 JF - Ugeskrift for laeger JO - Ugeskr Laeger VL - 156 IS - 14 N2 - Since 1992 it has been possible for cancer patients in the county of Southern Jutland to receive terminal care in their own homes. An essential part of this management is effective pain relief; more than 60% of cancer patients have chronic pain. In cases where oral medication or epidural administration of morphine is insufficient or complicated by side-effects continuous subcutaneous morphine administration may be suitable. The patient may be treated in this latter manner for long periods of time. A case story is described where a cancer patient was treated with continuous subcutaneous morphine in his home for more than 257 days without complications or major side-effects. SN - 0041-5782 UR - https://www.unboundmedicine.com/medline/citation/7516101/[Continuous_subcutaneous_morphine_to_patients_with_terminal_cancer__Analgesia_at_home]_ L2 - https://medlineplus.gov/homecareservices.html DB - PRIME DP - Unbound Medicine ER -